scholarly article | Q13442814 |
P50 | author | Sandosh Padmanabhan | Q29839671 |
Naveed Sattar | Q37378984 | ||
David Preiss | Q37840372 | ||
Nicholas L. Mills | Q42405715 | ||
Andrew H Briggs | Q80457814 | ||
P2093 | author name string | David Porteous | |
Mark Woodward | |||
Charles Boachie | |||
Paul Welsh | |||
Anoop S V Shah | |||
Archie Campbell | |||
Caroline Hayward | |||
David McAllister | |||
Alex McConnachie | |||
Claire Welsh | |||
P2860 | cites work | Human cardiac troponin complex. Structure and functions | Q26825137 |
High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study | Q28651794 | ||
High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis | Q34145900 | ||
Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin | Q35684928 | ||
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) | Q35773156 | ||
Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment? | Q36472407 | ||
Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study | Q37026476 | ||
High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease | Q37524838 | ||
Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. | Q37700011 | ||
Analytical characteristics of high-sensitivity cardiac troponin assays | Q37941605 | ||
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants | Q38657042 | ||
Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study). | Q39213764 | ||
Direct comparison of clinical decision limits for cardiac troponin T and I. | Q40960750 | ||
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population | Q41666469 | ||
Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age. | Q43976393 | ||
Outliers affecting cardiac troponin I measurement: comparison of a new high sensitivity assay with a contemporary assay on the Abbott ARCHITECT analyser | Q45066433 | ||
Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study | Q47139588 | ||
Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome | Q47414008 | ||
Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits | Q47794066 | ||
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease | Q48161023 | ||
Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study | Q48414365 | ||
Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Ma | Q48516288 | ||
Cardiac Troponin T and I Release After a 30-km Run. | Q48685870 | ||
Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. | Q50854096 | ||
The applied statistical approach highly influences the 99th percentile of cardiac troponin I. | Q51553297 | ||
High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris | Q61727650 | ||
Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction | Q62128944 | ||
Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population | Q84977707 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1607-1616 | |
P577 | publication date | 2018-08-20 | |
P1433 | published in | Clinical Chemistry | Q849687 |
P1476 | title | Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort | |
P478 | volume | 64 |
Q93086040 | A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicentre prospective cohort study |
Q90242232 | Cardiac Troponin T and Troponin I in the General Population |
Q90137109 | Early elevation in plasma high-sensitivity troponin T and morbidity after elective noncardiac surgery: prospective multicentre observational cohort study |
Q93053477 | High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome |
Q90243566 | Performance of High-Sensitivity Cardiac Troponin Assays To Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes |
Q95651532 | StatinImplications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders |
Search more.